TY - JOUR
T1 - Process formation of podocytes
T2 - Morphogenetic activity of microtubules and regulation by protein serine/threonine phosphatase PP2A
AU - Kobayashi, Naoto
AU - Reiser, Jochen
AU - Schwarz, Karin
AU - Sakai, Tatsuo
AU - Kriz, Wilhelm
AU - Mundel, Peter
N1 - Funding Information:
Acknowledgements The present study was supported by a grant from the “Deutsche Forschungsgemeinschaft (DFG)” to W.K. and P.M. who is currently supported by the Howard Hughes Medical Research Institute Research Resources for Medical Schools. N.K. was a research fellow of the Alexander von Humboldt Foundation (Bonn, Germany). J.R. was the recipient of a postdoctoral fellowship of the “Graduiertenkolleg Experimentelle Nieren-und Kreislaufforschung” of the DFG. We gratefully acknowledge Dr. J.B. Olmsted (University of Rochester, Rochester, N.Y., USA) for providing the MAP4 antibody, and Dr. S. Hisanaga (Tokyo Metropolitan University, Tokyo, Japan) for his generous gift of purified MAP4 protein as well as for critical reading of the manuscript.
PY - 2001
Y1 - 2001
N2 - Podocytes possess major processes containing microtubules (MTs) and intermediate filaments and foot processes containing actin filaments (AFs) as core cytoskeletal elements. Although the importance of these cytoskeletal elements for maintaining podocyte processes was previously shown, so far no data are available concerning the developmental regulation of podocyte process formation. A conditionally immortalized mouse podocyte cell line, which can be induced to develop processes similar to those found in vivo, was treated with various reagents to disrupt cytoskeletal elements or to inhibit protein phosphatases. MTs colocalized with vimentin intermediate filaments but not with AFs. After AF disassembly, major processes were maintained, whereas after depolymerization of MTs, podocytes lost their processes, rounded up, and maintained only actin-based peripheral projections. Suppression of MT elongation by nanomolar vinblastine or inhibition of serine/threonine phosphatase PP2A with okadaic acid abolished process formation. PP2A was expressed in undifferentiated but not in differentiated podocytes. One- and two-dimensional western blot analyses revealed a dose-dependent increase in serine/threonine phosphorylation after okadaic acid treatment. Hence, morphogenetic activity of MTs induces podocyte process formation via serine/threonine protein dephosphorylation by PP2A. These results may open new avenues for understanding the signaling mechanism underlying podocyte cytoskeleton alterations during development and in glomerular diseases.
AB - Podocytes possess major processes containing microtubules (MTs) and intermediate filaments and foot processes containing actin filaments (AFs) as core cytoskeletal elements. Although the importance of these cytoskeletal elements for maintaining podocyte processes was previously shown, so far no data are available concerning the developmental regulation of podocyte process formation. A conditionally immortalized mouse podocyte cell line, which can be induced to develop processes similar to those found in vivo, was treated with various reagents to disrupt cytoskeletal elements or to inhibit protein phosphatases. MTs colocalized with vimentin intermediate filaments but not with AFs. After AF disassembly, major processes were maintained, whereas after depolymerization of MTs, podocytes lost their processes, rounded up, and maintained only actin-based peripheral projections. Suppression of MT elongation by nanomolar vinblastine or inhibition of serine/threonine phosphatase PP2A with okadaic acid abolished process formation. PP2A was expressed in undifferentiated but not in differentiated podocytes. One- and two-dimensional western blot analyses revealed a dose-dependent increase in serine/threonine phosphorylation after okadaic acid treatment. Hence, morphogenetic activity of MTs induces podocyte process formation via serine/threonine protein dephosphorylation by PP2A. These results may open new avenues for understanding the signaling mechanism underlying podocyte cytoskeleton alterations during development and in glomerular diseases.
KW - Cytoskeleton
KW - Microtubules
KW - Podocyte (glomerular epithelial cell)
KW - Protein phosphatase type 2A (PP2A)
KW - Protein phosphorylation
UR - http://www.scopus.com/inward/record.url?scp=0035083218&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035083218&partnerID=8YFLogxK
U2 - 10.1007/s004180000242
DO - 10.1007/s004180000242
M3 - Article
C2 - 11326753
AN - SCOPUS:0035083218
SN - 0948-6143
VL - 115
SP - 255
EP - 266
JO - Histochemistry and Cell Biology
JF - Histochemistry and Cell Biology
IS - 3
ER -